Treatments w no or uncertain benefits oral steroids C antitussives C vasodilators B drugs for primary pulm HTN B mepolizumab benralizumab dupilumab nedocromil leukotriene modifiers infliximab immunostimulants beta blockers if no CV indication for use simv

By rray, 22 February, 2024
Exclude Patient Type Detail Header
No
Detail Type
Text
Patient Type Detail Header (Long)
<b>Treatments w/ no or uncertain benefits:</b> oral steroids [C], antitussives [C], vasodilators [B], drugs for primary pulm HTN [B], mepolizumab, benralizumab, dupilumab, nedocromil, leukotriene modifiers, infliximab, immunostimulants, beta-blockers (if no CV indication for use), simvastatin (if no CV indication) [A], vit D supplementation.<br><br>